# OnCo record paper-frampton-met-exon-14-cancer-discov-2015 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-frampton-met-exon-14-cancer-discov-2015/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-frampton-met-exon-14-cancer-discov-2015" ;
  schema:name "MET exon 14 splicing alterations across tumour types and their sensitivity to MET inhibitors"@en ;
  schema:description "This large sequencing study defined MET exon 14 skipping as a recurrent driver in about 3 percent of lung adenocarcinomas and other cancers, showed the mutations are diverse and easily missed, and reported patients responding to MET inhibitors."@en ;
  schema:url <https://onco.cc/key-papers/paper-frampton-met-exon-14-cancer-discov-2015/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1158/2159-8290.CD-15-0285>, <https://pubmed.ncbi.nlm.nih.gov/25971938/> ;
  schema:sameAs <https://doi.org/10.1158/2159-8290.CD-15-0285> ;
  schema:datePublished "2015"^^xsd:gYear ;
  schema:author "Frampton GM, Ali SM, Rosenzweig M, et al." ;
  onco:cancers <https://onco.cc/cancers/met-altered-nsclc/> ;
  onco:journals <https://onco.cc/journals/cancer-discovery/> .